Earnings calls / FINEOTEX_CHEMICAL

Fineotex Chemical Limited Q1 FY27 Earnings Call Summary

Fineotex delivered a transformative Q1 FY27, with total income of ₹386.72 crores (+165% YoY), EBITDA of ₹59.14 crores (+134.7% YoY, 15.70% margin), and PAT o...

Revenue
Margin
Demand
Guidance
Tone

Event Participants

Executives

4 Aarti Mitesh Jhunjhunwala, Arindam Choudhuri, Sanjay Surendra Tibrewala, Yusuf Contractor

Analysts

11 Akhilesh Pathak, Kriti Tripathi, Parth Modi, Prateek Giri, Rohit Ohri, Roshin Shah, Samarth Goel, Sunil Jain, Unknown Analyst, Utkarsh Somaiya, Vignesh Iyer

Financials & KPIs

Metric Reported Commentary
Total Income ₹386.72 crores +165% YoY vs ₹146.62 crores in Q1 FY26; driven by full-quarter contribution from US (CrudeChem) operations plus healthy domestic growth
Oil & Gas Revenue ~₹250 crores ~65% of consolidated revenue and ~55% of volumes; CrudeChem run-rate annualizes to ~₹1,000 crores
Gross Profit ₹133.4 crores Gross margin 35.42% vs ~33% YoY and ~29-30% in Q4 FY26; higher raw material costs successfully passed on to customers
EBITDA ₹59.14 crores +134.7% YoY vs ₹25.2 crores in Q1 FY26; EBITDA margin 15.70% vs 13.93% in Q4 FY26 (+~150 bps QoQ), vs ~18% a year ago on a much lower base
PAT ₹48.21 crores +92.67% YoY vs ₹25.03 crores in Q1 FY26
Working Capital Cycle 72 days Reflects disciplined capital management while supporting scale-up of international operations
ROIC 33.06% High-margin specialty product mix drives returns
ROCE 25.56%
ROE ~20%
Manufacturing Capacity (Texas) 148,000 MTPA Expanded from 80,000 MTPA during the quarter; total group capacity now 268,000 MTPA; Texas utilization ~63% on single shift
Export Mix 77% of revenue Up from 70%; international classification includes output from US and Malaysia plants, not only Indian exports
Dealer Network 115 dealers Up from 103; growth predominantly in legacy Fineotex India business since CrudeChem serves end users directly

Geographic & Segment Commentary

  • Textile Specialty Chemicals: Resilient but flattish quarter (~₹132-137 crores ex-CrudeChem vs ₹137 crores in Q1 FY26, a minor 1-2% dip attributed to Q1 monsoon seasonality and competitive Indian textile market). R&D pipeline spans pretreatment, dyeing, finishing and functional textiles; technical textiles (automotive, medical, industrial, infrastructure) seen as long-term growth driver. Management expects improvement via Bangladesh technical team expansion and Bharat Tex exhibition leads.
  • Oil & Gas Specialty Chemicals (CrudeChem): Contributed ₹250 crores (65% of revenue, ~55% of volumes) in Q1 FY27 across production chemicals, water treatment, flow assurance and other specialty formulations. Texas capacity expansion to 148,000 MTPA plus Midland facility provides operational flexibility and access to larger contracts. Significant EBITDA margin improvement post-acquisition, with CrudeChem margins now at a minimum 13-14%.
  • International Operations: Products serve customers across 70+ countries. Saudi win secured - a customer's $8 billion Aramco order requires Fineotex's specialty package (5-6 product lines), competing against top US specialty chemical majors. Canada sales commenced last month; service operators are requesting local plant setup in Suriname and Guyana, under evaluation.

Company-Specific & Strategic Commentary

  • CrudeChem Acquisition & Integration: Acquired December 9, 2025 (majority stake, fully consolidated under Ind AS); described as a "growth capital" partnership where Fineotex funding enabled CrudeChem to scale. Synergies include technology transfer, cross-selling (including Asia-made products from India/Malaysia to US customers), better supplier pricing through capital infusion, and R&D hires in the US.
  • Texas Capacity Expansion: Commissioned expansion adding ~69,000 MTPA, taking Texas capacity from 80,000 to 148,000 MTPA; enables larger customer contracts and participation in bigger commercial opportunities across US oil-producing regions.
  • M&A Discipline & Pipeline: Two acquisitions in 15 years (Malaysia-based European specialty chemical producer with 72% stake in August 2011; CrudeChem in December 2025). Selection parameters are synergy and shareholder value; Yusuf Contractor, an experienced global specialty chemicals M&A leader, heads the effort; management is actively evaluating opportunities but will only disclose at an advanced stage.
  • Sustainability & Green Chemistry: ESG focus reinforced with Dun & Bradstreet ESG profile badge; green chemistry portfolio commands better profitability and is increasingly specified by customers in both textile and oilfield segments.
  • Service-Led Model (FrackMex): Last-mile delivery entity with proprietary telematics retained as a competitive differentiator; US customers pay premium for door-level service, and the entity is ring-fenced separately for insurance and liability management (auto, workmen, driver insurances; US litigation culture).
  • Tax-Efficient Structure: New Indian plant (commissioned August 2025) operates under FSPL Speciality Private Limited, a 100% subsidiary availing Section 115BAB tax regime (15% vs 20-25%).

Guidance & Outlook

Metric Guidance / Outlook Commentary
Oil & Gas Revenue (CrudeChem) $100 million FY27; $200 million FY28 Order book and customer engagement driven, not crude oil price contingent; higher crude prices support US activity as a tailwind; production investments locked 2+ years ahead cushion against price declines
Texas Capacity Utilization Full utilization in "coming few quarters" Currently 63% on single shift; 30-40% headroom on existing capacity; second shift can nearly double output with minimal capex ($1-2 million, immaterial per management)
EBITDA Margin No formal guidance; aspiration for improvement Management declined fixed margin targets citing a 100+ product basket requiring mix flexibility; earlier indicated trajectory toward 18%
Textile Business Flattish near-term, improving bias Tariff normalization with UK/EU/US, Bangladesh team expansion, international exhibitions; historical 30%+ CAGR track record cited as evidence of resilience
International Expansion Active pipeline Canada sales begun; Suriname/Guyana plant setup under discussion with service operators; Saudi Aramco-linked specialty package win validates competitive positioning

Risks & Constraints

Risk Context
Geopolitical / Raw Material Volatility Middle East conflict has caused global chemical price swings; management mitigates through US "war surcharge"/fuel surcharge pass-through mechanisms and maintains absolute per-unit margins, but input cost trajectory remains unpredictable
Crude Oil Price Decline If crude falls to ~$60, US drilling activity could slow; management argues committed upstream/downstream investments keep production running and guidance is order-book driven, but admits $200 million FY28 target could slip under sustained weakness
Customer Concentration Oil & gas now ~65% of revenue, concentrated among top global service operators (Shell, Exxon, Halliburton et al.); well-based demand is bunched and weather-sensitive (storms, snowfall), creating quarterly volatility
Textile Competition & Seasonality Indian textile chemicals market is competitive; Q1 monsoon seasonality pressured volumes; flattish base textile revenue; recovery contingent on tariff normalization and demand shifts toward premium sustainable products
Integration Execution CrudeChem (majority-owned) is scaling through a capacity doubling, technology transfer and working capital expansion; CrudeChem EBITDA margins of 13-14% must hold while scaling toward $200 million revenue by FY28

Q&A Highlights

Capacity Expansion & Growth Trajectory

  • Question: With Texas capacity expanded to 148,000 MTPA (from 80,000) and group capacity at 268,000 MTPA, what top-line and bottom-line growth can be expected? (Kriti Tripathi)
  • Answer: Texas ran at only 63% utilization; another 30-40% revenue can be added on existing capacity, making Q1 FY27 a base quarter. Oil & gas now contributes 65% of revenue and 55% of volumes. (Sanjay Tibrewala)

Inorganic Growth Pipeline

  • Question: Have specific M&A targets been identified, in which segments, and what is the timeline? (Kriti Tripathi)
  • Answer: Constantly evaluating opportunities against two parameters: synergy and shareholder value. CrudeChem was a "perfect synergy" where Fineotex provided growth capital. Yusuf Contractor, an experienced global specialty chemicals M&A leader, heads the effort. Stock exchange disclosure will follow when deals reach an advanced stage. (Sanjay Tibrewala)

Oil & Gas Revenue Guidance & Crude Price Sensitivity

  • Question: What crude price is built into the $100M FY27/$200M FY28 guidance - order book or crude-linked? Would $60 crude push back the FY28 target? (Parth Modi)
  • Answer: Guidance is order book and customer engagement driven, not crude-linked. Higher crude supports US activity, but even at $60, production cannot stop - extraction investments are committed 2+ years ahead. (Sanjay Tibrewala)
  • Question: End market is growing only 5-7% CAGR - what will drive $200 million? (Roshin Shah)
  • Answer: Management has historically doubled despite modest industry growth; sustainability tailwinds, references from top service operators, snowball replication effect, and better supplier pricing post-capital infusion support the target, which remains on track for December 2028. (Sanjay Tibrewala)

Margin Trajectory & Sustainability

  • Question: Margins reached 16% from 14% - still on the path to 18%, or can you do better? (Utkarsh Somaiya)
  • Answer: No fixed blended margin guidance is possible with a 100+ product basket; refusing volume contracts is not the strategy. Management aspires to better margins while prioritizing market leadership and customer engagement. (Sanjay Tibrewala)
  • Question: What is CrudeChem's standalone EBITDA margin? (Sunil Jain)
  • Answer: CrudeChem margins are "minimum 13-14%," significantly improved post-acquisition via technology transfers, cost reductions, and green chemistry demand; blended consolidated margin is 15.7%, up from 13.93% last quarter. (Sanjay Tibrewala)
  • Question: Are recent margins sustainable or a war-driven one-off? (Unknown Analyst)
  • Answer: Margins are sustainable - Fineotex is not a commodity trader. The US war/fuel surcharge pass-through mechanism is well-established; customers have digested the new pricing normal, and absolute per-unit margins are maintained in both directions. (Sanjay Tibrewala)

Textile Business Flattish Performance

  • Question: Consolidated ₹377 crores minus CCTL ₹245 crores gives ₹132 crores vs ₹137 crores in Q1 FY26 - is there still a dip? (Prateek Giri)
  • Answer: Minor 1-2% is flattish; Q1 monsoon seasonality and trend shifts between expensive/sustainable products explain the variation, plus Indian textile competition. Improvement expected - Bangladesh marketing and technical services team expanded, Bharat Tex generated significant opportunities. (Sanjay Tibrewala)

India Standalone Dip Explained - FSPL

  • Question: Standalone revenue and EBITDA showed marginal decline - seasonal or structural? (Sunil Jain)
  • Answer: Purely optical. The new plant (commissioned August 2025) operates under FSPL Specialities, a 100% subsidiary availing Section 115BAB (15% tax vs 20-25%). Combining FCL standalone plus FSPL shows no dip. (Sanjay Tibrewala)

Ownership, Consolidation & Forex Accounting

  • Question: Since Fineotex owns ~53% of CrudeChem, should only ~$50M of the $100M guidance reflect in consolidated revenue? (Utkarsh Somaiya)
  • Answer: Under Ind AS, majority controlling stake requires full consolidation. US operations already contribute ₹250 crores per quarter, annualizing to ~₹1,000 crores ($100 million); non-controlling interest details are in published results. (Sanjay Tibrewala)
  • Question: Are forex gains/losses recognized in other income or EBITDA? (Vignesh Iyer)
  • Answer: Declared separately as a forex item per Ind AS. CrudeChem buys and sells entirely in USD with natural hedging through USD raw material imports, so Indian rupee conversion exposure is minimal. (Sanjay Tibrewala)

Synergies, Order Book & New Market Wins

  • Question: Can you quantify operational synergies and provide the CCT order book? (Samarth Goel)
  • Answer: Synergies span technology transfer, customer handling, cross-selling, and better supplier pricing from capital infusion. There is no traditional order book - well-based demand is perennial but bunched, and weather disruptions (storms, snowfall) cause short-term pauses. (Sanjay Tibrewala)
  • Question: Are you targeting Canada, Venezuela, and Gulf customers beyond Texas? (Akhilesh Pathak)
  • Answer: Canada sales started last month; US-controlled oil producers in Suriname and Guyana are asking for local plant setups. Saudi order won - the customer's $8 billion Aramco contract requires Fineotex's specialty package (5-6 product lines), competing against top US specialty chemical firms on pricing and performance. (Sanjay Tibrewala)

Last-Mile Logistics - FrackMex

  • Question: Does it make sense to keep or hive off the logistics entity with proprietary telematics? (Rohit Ohri)
  • Answer: US is a service-oriented market - customers pay premium for door-level delivery, and owned transport is a competitive advantage. FrackMex is kept separate for insurance and liability reasons (auto, workmen, driver insurances; US litigation culture) and is an intrinsic part of the CrudeChem model. (Sanjay Tibrewala)

Key Takeaway

Fineotex delivered a transformative Q1 FY27, with total income of ₹386.72 crores (+165% YoY), EBITDA of ₹59.14 crores (+134.7% YoY, 15.70% margin), and PAT of ₹48.21 crores (+92.7% YoY), driven by full-quarter consolidation of CrudeChem, which contributed 65% of revenue (₹250 crores) at 63% capacity utilization. The Texas facility expansion to 148,000 MTPA underpins the $100 million FY27/$200 million FY28 oil & gas revenue targets, supported by a Saudi Aramco-linked specialty package win, Canada market entry, and Suriname/Guyana opportunities. The textile business held flattish on monsoon seasonality and competition, with improvement expected from Bangladesh expansion and Bharat Tex leads. Management maintains disciplined capital allocation (72-day working capital cycle, ROIC 33.06%, ROCE 25.56%, ROE ~20%) while pursuing synergistic M&A. Key watch points include Middle East-driven raw material volatility, customer concentration in oil & gas, and CrudeChem integration execution as capacity scales toward full utilization.

What you get with InvestorStack

Institutional-grade research, built for individual investors.

  • Research Reports for 1,800+ companies
  • Detailed valuation models
  • Growth triggers, Risks, KPIs, Read between the lines
  • Scans, One pagers, Industry research reports
Try for free